Lv1
20 积分 2023-08-20 加入
Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma
10小时前
已完结
Gastric SMARCA4-Deficient Undifferentiated Carcinoma: A Report of 4 Patients and Literature Review
7天前
已完结
Identification and Treatment of SMARCA4 Deficient Poorly Differentiated Gastric Carcinoma
7天前
已完结
A case report of SMARCA4-deficient undifferentiated tumor in the esophago-gastric junction
7天前
已完结
Infigratinib Versus Placebo for Patients with High-risk Resected Urothelial Cancer Bearing an FGFR3 Genomic Alteration: Results from the PROOF302 Phase 3 Trial
11天前
已完结
Reduced-Dose Enfortumab Vedotin, Treatment Continuity, and Survival in Urothelial Cancer
11天前
已完结
HER2-directed therapy improves urothelial cancer outcomes
13天前
已完结
Determinants of sensitivity to HER2-targeted antibody drug conjugates in urothelial cancer
14天前
已完结
Gastric SMARCA4-Deficient Undifferentiated Carcinoma: A Report of 4 Patients and Literature Review
15天前
已完结
Clinical outcomes and immune contexture in SMARCA4 ‐deficient gastric cancer patients
15天前
已完结
皖公网安备34019202002308
